A systematic approach to the development of a safe live attenuated Zika vaccine

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2041-1723
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
A systematic approach to the development of a safe live attenuated Zika vaccine ; volume:9 ; number:1 ; day:12 ; month:3 ; year:2018 ; pages:1-13 ; date:12.2018
Nature Communications ; 9, Heft 1 (12.3.2018), 1-13, 12.2018

Urheber
Kwek, Swee Sen
Beteiligte Personen und Organisationen
Watanabe, Satoru
Chan, Kuan Rong
Ong, Eugenia Z.
Tan, Hwee Cheng
Ng, Wy Ching
Nguyen, Mien T. X.
Gan, Esther S.
Zhang, Summer L.
Chan, Kitti W. K.
Tan, Jun Hao
Sessions, October M.
Manuel, Menchie
Pompon, Julien
Chua, Camillus
Hazirah, Sharifah
Tryggvason, Karl
Vasudevan, Subhash G.
Ooi, Eng Eong
SpringerLink (Online service)

DOI
10.1038/s41467-018-03337-2
URN
urn:nbn:de:1111-201805121588
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:48 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Kwek, Swee Sen
  • Watanabe, Satoru
  • Chan, Kuan Rong
  • Ong, Eugenia Z.
  • Tan, Hwee Cheng
  • Ng, Wy Ching
  • Nguyen, Mien T. X.
  • Gan, Esther S.
  • Zhang, Summer L.
  • Chan, Kitti W. K.
  • Tan, Jun Hao
  • Sessions, October M.
  • Manuel, Menchie
  • Pompon, Julien
  • Chua, Camillus
  • Hazirah, Sharifah
  • Tryggvason, Karl
  • Vasudevan, Subhash G.
  • Ooi, Eng Eong
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine

Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine

Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone

Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone

Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone

Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone

A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs

A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs

Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells

Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells

Development of a live attenuated human cytomegalovirus vaccine strain

Hochschulschrift

Development of a live attenuated human cytomegalovirus vaccine strain

Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens

Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens

Zika: How safe is India?

Zika: How safe is India?

An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission

An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission

A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections

A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections

Generation of an attenuated chimeric bat influenza A virus live-vaccine prototype

Generation of an attenuated chimeric bat influenza A virus live-vaccine prototype

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate

Verbundene Objekte